Sectral and Depakote drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sectral (acebutolol hydrochloride) and Depakote (divalproex sodium). Common drug interactions include loss of consciousness among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Sectral and Depakote. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Sectral?

Sectral has active ingredients of acebutolol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 3,548 Sectral users. Check the latest studies of Sectral.

What is Depakote?

Depakote has active ingredients of divalproex sodium. It is often used in bipolar disorder. eHealthMe is studying from 55,581 Depakote users. Check the latest studies of Depakote.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 17, 2026

17 people who take Sectral and Depakote together, and have interactions are studied.

Sectral and Depakote drug interactions.

What are the common drug interactions of Sectral and Depakote, by gender? *:

female:

  1. Loss of consciousness
  2. Chest pain
  3. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  4. Atrial tachycardia (rhythm disturbance that arises in the atria)
  5. Biliary tract disorder
  6. Blood cholesterol increased
  7. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  8. Dental caries
  9. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  10. Hypokalaemia (low potassium)

male:

  1. Fall
  2. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  3. Atelectasis (partial or complete collapse of the lung)
  4. Balance disorder
  5. Blood albumin decreased
  6. Blood glucose increased
  7. Bone disorder
  8. Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
  9. Cardiac failure congestive
  10. Colonic polyp (extra part of colon tissue grow in intestine)

What are the common drug interactions of Sectral and Depakote, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Atrial tachycardia (rhythm disturbance that arises in the atria)
  2. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  3. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  4. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)

50-59:

n/a

60+:

  1. Fall
  2. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  3. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  4. Anaemia (lack of blood)
  5. Atelectasis (partial or complete collapse of the lung)
  6. Balance disorder
  7. Blood albumin decreased
  8. Blood glucose increased
  9. Bone disorder
  10. Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 3 people, 17.65%
  2. Ischaemic Cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease): 3 people, 17.65%
  3. Insomnia (sleeplessness): 3 people, 17.65%
  4. Depression: 3 people, 17.65%
  5. Osteoporosis (bones weak and more likely to break): 2 people, 11.76%
  6. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 5.88%
  7. Intervertebral Disc Degeneration (spinal disc degeneration): 1 person, 5.88%
  8. Ill-Defined Disorder: 1 person, 5.88%
  9. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 5.88%
  10. High Blood Cholesterol: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Sectral and Depakote?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sectral and Depakote:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sectral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Depakote:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sectral and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Depakote and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acebutolol hydrochloride and divalproex sodium (the active ingredients of Sectral and Depakote, respectively), and Sectral and Depakote (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: